Subclinical atrial fibrillation in older patients

Circulation

Volumn 136, Issue 14, 2017, Pages 1276-1283

  Healey, Jeff S ^a,b   Alings, Marco ^c,d   Ha, Andrew ^e   Leong Sit, Peter ^f   Birnie, David H ^g   De Graaf, Jacob J ^h   Freericks, Michel ⁱ   Verma, Atul ^e   Wang, Jia ^a,b   Leong, Darryl ^a,b   Dokainish, Hisham ^a,b   Philippon, Francois ^j   Barake, Walid ^k   McIntyre, William F ^a,b   Simek, Kim ^a   Hill, Michael D ^l   Mehta, Shamir R ^a,b   Carlson, Mark ^m   Smeele, Frank ⁿ   Pandey, A Shekhar ^b,o   Connolly, Stuart J ^a,b   more..

^a HAMILTON HEALTH SCIENCES   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c AMPHIA HOSPITAL   (Netherlands)

^d WCN Dutch Network for Cardiovascular Research   (Netherlands)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF WESTERN ONTARIO   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

^h NIJ SMELLINGHE HOSPITAL   (Netherlands)

ⁱ IKAZIA HOSPITAL   (Netherlands)

^j LAVAL UNIVERSITY   (Canada)

^k UNIVERSITY OF ALBERTA   (Canada)

^l UNIVERSITY OF CALGARY   (Canada)

^m ST JUDE MEDICAL   (United States)

ⁿ SLINGELAND HOSPITAL   (Netherlands)

^o Cambridge Cardiac Care Inc   (Canada)

more..

Author keywords

Atrial fibrillation; Monitoring; Physiologic; Stroke

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

AGED; ARTICLE; ATRIAL FIBRILLATION; BLEEDING; BLOOD PRESSURE; BODY MASS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL OUTCOME; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FLUTTER; HEART FAILURE; HEART REHABILITATION; HEART SURGERY; HEMATOMA; HUMAN; INFECTION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NEUROLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANK SUM TEST; SLEEP DISORDERED BREATHING; SPEECH DISORDER; TRANSIENT ISCHEMIC ATTACK; CARDIOVASCULAR DISEASES; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; RISK FACTORS;

EID: 85030781158     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.117.028845     Document Type: Article

References (17)

1. Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A, Witteman JC, Stricker BH, Heeringa J. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34:2746-2751. doi: 10.1093/eurheartj/eht280.
2. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH; ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366:120-129. doi: 10.1056/NEJMoa1105575.
3. Swiryn S, Orlov MV, Benditt DG, DiMarco JP, Lloyd-Jones DM, Karst E, Qu F, Slawsky MT, Turkel M, Waldo AL; RATE Registry Investigators. Clinical implications of brief device-detected atrial tachyarrhythmias in a cardiac rhythm management device population: results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes. Circulation. 2016;134:1130-1140. doi: 10.1161/CIRCULATIONAHA.115.020252.
4. Botto GL, Padeletti L, Santini M, Capucci A, Gulizia M, Zolezzi F, Favale S, Molon G, Ricci R, Biffi M, Russo G, Vimercati M, Corbucci G, Boriani G. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol. 2009;20:241-248. doi: 10.1111/j.1540-8167.2008.01320.x.
5. Hess PL, Healey JS, Granger CB, Connolly SJ, Ziegler PD, Alexander JH, Kowey PR, Ruff CT, Flaker G, Halperin JL, Hart RG, Lopes RD. The role of cardiovascular implantable electronic devices in the detection and treatment of subclinical atrial fibrillation: a review. JAMA Cardiol. 2017;2:324-331. doi: 10.1001/jamacardio.2016.5167.
6. Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C, Miller C, Qi D, Ziegler PD. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol. 2009;2:474-480. doi: 10.1161/CIRCEP.109.849638.
7. Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, Rymer MM, Thijs V, Rogers T, Beckers F, Lindborg K, Brachmann J; CRYSTAL AF Investigators. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370:2478-2486. doi: 10.1056/NEJMoa1313600.
8. Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, Vaid H, O'Donnell M, Laupacis A, Côté R, Sharma M, Blakely JA, Shuaib A, Hachinski V, Coutts SB, Sahlas DJ, Teal P, Yip S, Spence JD, Buck B, Verreault S, Casaubon LK, Penn A, Selchen D, Jin A, Howse D, Mehdiratta M, Boyle K, Aviv R, Kapral MK, Mamdani M; EMBRACE Investigators and Coordinators. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014;370:2467-2477. doi: 10.1056/NEJMoa1311376.
9. Tsang TS, Barnes ME, Bailey KR, Leibson CL, Montgomery SC, Takemoto Y, Diamond PM, Marra MA, Gersh BJ, Wiebers DO, Petty GW, Seward JB. Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women. Mayo Clin Proc. 2001;76:467-475. doi: 10.4065/76.5.467.
10. Patton KK, Ellinor PT, Heckbert SR, Christenson RH, DeFilippi C, Gottdiener JS, Kronmal RA. N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study. Circulation. 2009;120:1768-1774. doi: 10.1161/CIRCULATIONAHA.109.873265.
11. Nölker G, Mayer J, Boldt LH, Seidl K, VAN Driel V, Massa T, Kollum M, Brachmann J, Deneke T, Hindricks G, Jung W, Brunner KJ, Kraus S, Hümmer A, Lewalter T. Performance of an implantable cardiac monitor to detect atrial fibrillation: results of the DETECT AF Study. J Cardiovasc Electrophysiol. 2016;27:1403-1410. doi: 10.1111/jce.13089.
12. Bloch Thomsen PE, Jons C, Raatikainen MJ, Moerch Joergensen R, Hartikainen J, Virtanen V, Boland J, Anttonen O, Gang UJ, Hoest N, Boersma LV, Platou ES, Becker D, Messier MD, Huikuri HV; Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) Study Group. Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study. Circulation. 2010;122:1258-1264. doi: 10.1161/CIRCULATIONAHA.109.902148.
13. Bonetti M, Gelber RD. Patterns of treatment effects in subsets of patients in clinical trials. Biostatistics. 2004;5:465-481. doi: 10.1093/biostatistics/5.3.465.
14. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1-39.e14. doi: 10.1016/j.echo.2014.10.003.
15. Camm AJ, Simantirakis E, Goette A, Lip GY, Vardas P, Calvert M, Chlouverakis G, Diener HC, Kirchhof P. Atrial high-rate episodes and stroke prevention. Europace. 2017;19:169-179. doi: 10.1093/europace/euw279.
16. Macle L, Cairns JA, Andrade JG, Mitchell LB, Nattel S, Verma A; CCS Atrial Fibrillation Guidelines Committee. The 2014 atrial fibrillation guidelines companion: a practical approach to the use of the Canadian Cardiovascular Society Guidelines. Can J Cardiol. 2015;31:1207-1218. doi: 10.1016/j.cjca.2015.06.005.
17. Virnig BA, Shippee ND, O'Donnell B, Zeglin J, Parashuram S. Trends in the use of echocardiography, 2007 to 2011. Rockville, MD: Agency for Healthcare Research and Quality; May 13, 2014. Data Points No. 20. http://www.ahrq.gov. Accessed April 14, 2017.